These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2525858)

  • 21. Relationships of follicle versus oocyte maturity to ultrasound morphology, blood flow, and hormone concentrations of the preovulatory follicle in mares.
    Ginther OJ; Gastal EL; Gastal MO; Siddiqui MA; Beg MA
    Biol Reprod; 2007 Aug; 77(2):202-8. PubMed ID: 17475927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of IGF-I on pig oocyte maturation, fertilization, and early embryonic development in vitro, and on granulosa and cumulus cell biosynthetic activity.
    Xia P; Tekpetey FR; Armstrong DT
    Mol Reprod Dev; 1994 Aug; 38(4):373-9. PubMed ID: 7980945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flow cytometric analysis of deoxyribonucleic acid in human granulosa cells from in vitro fertilization cycles: relationships to oocyte maturity and fertilizability and to follicular fluid steroids.
    Ben-Rafael Z; Varello MA; Meloni F; Fateh M; Mastroianni L; Flickinger GL
    J Clin Endocrinol Metab; 1987 Oct; 65(4):602-5. PubMed ID: 3116026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of insulin-like growth factor-I during preantral follicular culture on steroidogenesis, in vitro oocyte maturation, and embryo development in mice.
    Demeestere I; Gervy C; Centner J; Devreker F; Englert Y; Delbaere A
    Biol Reprod; 2004 Jun; 70(6):1664-9. PubMed ID: 14960488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concentrations of follicle regulatory protein, steroids and gonadotrophins in antral fluids from women stimulated with metrodin and hCG.
    Tonetta SA; Stone BA; Marrs RP; diZerega GS
    J Reprod Fertil; 1990 Jan; 88(1):389-97. PubMed ID: 2107303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients.
    Smitz J; Andersen AN; Devroey P; Arce JC;
    Hum Reprod; 2007 Mar; 22(3):676-87. PubMed ID: 17110397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do analogues of gonadotrophin releasing hormone influence follicular fluid steroid levels, oocyte maturity and fertilization rates?
    Tavmergen E; Tavmergen EN; Capanoğlu R
    Hum Reprod; 1992 Apr; 7(4):479-82. PubMed ID: 1387881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of follicular fluid hormones in patients with one or two ovaries participating in a program of in vitro fertilization.
    Alper MM; Seibel MM; Oskowitz SP; Taymor ML
    Fertil Steril; 1987 Jul; 48(1):94-7. PubMed ID: 3595917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential use of clomiphene citrate, human menopausal gonadotropin, and human chorionic gonadotropin in human in vitro fertilization. I. Follicular growth and oocyte suitability.
    Plachot M; Mandelbaum J; Cohen JJ; Debache C; Pigeau F; Junca AM
    Fertil Steril; 1985 Feb; 43(2):255-62. PubMed ID: 3917950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro effects of insulin-like growth factors and insulin on oocyte maturation and maturation-inducing steroid production in ovarian follicles of common carp, Cyprinus carpio.
    Mukherjee D; Mukherjee D; Sen U; Paul S; Bhattacharyya SP
    Comp Biochem Physiol A Mol Integr Physiol; 2006 May; 144(1):63-77. PubMed ID: 16531089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential regulation of inhibin B and inhibin a by follicle-stimulating hormone and local growth factors in human granulosa cells from small antral follicles.
    Welt CK; Schneyer AL
    J Clin Endocrinol Metab; 2001 Jan; 86(1):330-6. PubMed ID: 11232020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IGF-I and epidermal growth factor levels in follicular fluid of women undergoing controlled ovarian hyperstimulation using the multidose GnRH-antagonist protocol or the long GnRH-agonist protocol.
    Asimakopoulos B; Schöpper B; Dawson A; Caglar GS; Vakalopoulos I; Al-Hasani S; Diedrich K; Nikolettos N
    J Endocrinol Invest; 2006 May; 29(5):RC5-8. PubMed ID: 16794358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth differentiation factor-9 stimulates proliferation but suppresses the follicle-stimulating hormone-induced differentiation of cultured granulosa cells from small antral and preovulatory rat follicles.
    Vitt UA; Hayashi M; Klein C; Hsueh AJ
    Biol Reprod; 2000 Feb; 62(2):370-7. PubMed ID: 10642575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of GnRHa ovulation trigger dose on follicular fluid characteristics and granulosa cell gene expression profiles.
    Vuong TNL; Ho MT; Ha TQ; Jensen MB; Andersen CY; Humaidan P
    J Assist Reprod Genet; 2017 Apr; 34(4):471-478. PubMed ID: 28197932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of urinary and recombinant follicle-stimulating hormone in in vitro growth, maturation, and fertilization of mouse preantral follicles.
    Calongos G; Hasegawa A; Komori S; Koyama K
    Fertil Steril; 2008 May; 89(5 Suppl):1482-9. PubMed ID: 17854805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of follicular fluid IGF-I, IGF-II, IGFBP-3, IGFBP-4 and PAPP-A concentrations and their ratios between GnRH agonist and GnRH antagonist protocols for controlled ovarian stimulation in IVF-embryo transfer patients.
    Choi YS; Ku SY; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Hum Reprod; 2006 Aug; 21(8):2015-21. PubMed ID: 16601008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum hormones, follicular fluid steroids, insulin-like growth factors and their binding proteins, and ovarian IGF mRNA in sheep with different ovulation rates.
    Spicer LJ; Echternkamp SE; Wong EA; Hamilton DT; Vernon RK
    J Anim Sci; 1995 Apr; 73(4):1152-63. PubMed ID: 7543085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of the efficiency of controlled ovarian hyperstimulation in the gonadotropin-releasing hormone agonist-suppression cycle using the initial follicle count during gonadotropin stimulation.
    Huang FJ; Chang SY; Tsai MY; Kung FT; Wu JF; Chang HW
    J Assist Reprod Genet; 2001 Feb; 18(2):91-6. PubMed ID: 11285987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-like growth factor II (IGF-II) and follicle stimulating hormone (FSH) combinations can improve the in vitro development of grown oocytes enclosed in caprine preantral follicles.
    Duarte AB; Araújo VR; Chaves RN; da Silva GM; Luz VB; Haag KT; Magalhães-Padilha DM; Almeida AP; Lobo CH; Campello CC; de Figueiredo JR
    Growth Horm IGF Res; 2013; 23(1-2):37-44. PubMed ID: 23333247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.